Jubilant Pharmova consolidated net profit declines 45.09% in the June 2026 quarter
(11 Aug 2026)
Back
Net profit of Jubilant Pharmova declined 45.09% to Rs 56.50 crore in the quarter ended June 2026 as against Rs 102.90 crore during the previous quarter ended June 2025. Sales rose 18.21% to Rs 2221.10 crore in the quarter ended June 2026 as against Rs 1878.90 crore during the previous quarter ended June 2025.
| Particulars | Quarter Ended | | Jun. 2026 | Jun. 2025 | % Var. |
| Sales | 2221.10 | 1878.90 | 18 |
| OPM % | 11.17 | 15.41 | - |
| PBDT | 213.70 | 252.50 | -15 |
| PBT | 86.40 | 154.40 | -44 |
| NP | 56.50 | 102.90 | -45 |
|